NCT00507442
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,057 public trials
2,038 recruiting studies
Lymphoproliferative Disorders trial results
Completed
Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
NCT00006760
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
- Locations
-
- Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Southern California Permanente Medical Group Downey, California, United States
NCT00749502
- Conditions
- Adnexal Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +38 more
- Locations
-
Not specified
Completed
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
NCT00564512
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Centre Henri Becquerel Rouen, France
NCT01387841
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +19 more
- Locations
-
- Health Care Global Bangalore, Karnataka, India
NCT00054327
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +51 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00842595
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Hôpital COCHIN Paris, France
NCT00496860
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +66 more
- Locations
-
- University of Colorado, Anschutz Cancer Pavillion Aurora, Colorado, United States
- MD Anderson Cancer Center Orlando Orlando, Florida, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
- University of Washington, Seattle Cancer Care Center Seattle, Washington, United States
Completed
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
NCT00049686
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
- Locations
-
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
Completed
Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
NCT00723359
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Emory University Winship Cancer Institute Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Mount Sinai Medical Center New York, United States